Humanigen Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science. | XOMA XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics. | Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | |||
Founding Date | Founding Date 2000 | Founding Date 1998 | Founding Date 1981 | Founding Date 1997 | Founding Date 1976 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Burlingame, US HQ Dublin, IE London, GB Kansas City, US | Locations Emeryville, US HQ | Locations Chicago, US HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Vacaville, US | |
Employees | Employees 233% decrease | Employees 1,49229% increase | Employees 109% decrease | Employees 1 | Employees 20,3311% decrease |
Valuation ($) | Valuation ($) 4.3 m | Valuation ($) 5.5 b | Valuation ($) 345.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $2.5m (FY, 2022) | Revenue (est.) £361.7m (FY, 2022) | Revenue (est.) $4.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($70.7m) (FY, 2022) | Net income (£8.5m) (FY, 2022) | Net income ($40.8m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 131.7m | Total funding raised $ 78.8m | Total funding raised N/A | Total funding raised $ 200k | Total funding raised N/A |